Gene · 8542
Papers3,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond the test: patient-reported concerns and worries regarding kidney conditions and APOL1 genetic testing among Black patients. | Front Nephrol | 2026 | 42558935 | PubTator, text mining | PubMed |
| Protective Effect of the Apolipoprotein L1 p.N264K Variant Against CKD among People with HIV Carrying Apolipoprotein L1 High-Risk Genotypes. | J Am Soc Nephrol | 2026 | 42545739 | PubTator, text mining | PubMed |
| Angiotensin system modulation in focal segmental glomerulosclerosis: pharmacological basis and clinical implications. | Expert Opin Pharmacother | 2026 | 42525818 | PubTator, text mining | PubMed |
| Associations of Nephron Number, Birth Weight, and Causes of Death in a Community at High Risk of Hypertension and Cardiovascular Disease. | Kidney Med | 2026 | 42499453 | PubTator, text mining | PubMed |
| APOL1-Mediated Kidney Disease and the Emerging Era of Precision Therapy. | Annu Rev Med | 2026 | 42480070 | PubTator, text mining | PubMed |
| Genetic Evaluation Practices in Living Kidney Donor Candidates. | Kidney Int Rep | 2026 | 42473677 | PubTator, text mining | PubMed |
| Peri-Transplant Apolipoprotein L1 Pore Inhibition in High-Risk Donor Kidneys: A Testable Hypothesis. | Nephron | 2026 | 42464507 | PubTator, text mining | PubMed |
| Integrative analysis prioritizes proteins associated with renal cell carcinoma and its risk factors. | JNCI Cancer Spectr | 2026 | 42439544 | PubTator, text mining | PubMed |
| APOL1 Variants, AKI, and Progression to Kidney Failure in People of African Ancestry Living with HIV. | Kidney Int Rep | 2026 | 42382183 | PubTator, text mining | PubMed |
| A Scoping Review of Toolkits Addressing Ethical Issues in Health Registry and Clinical Research Enrollment Among African Americans With CKD. | Kidney Med | 2026 | 42375689 | PubTator, text mining | PubMed |
| Expression of APOL1 and NOTCH2 genes in patients with type 2 diabetes mellitus attending babcock University Teaching Hospital, Ogun State, Nigeria. | Sci Rep | 2026 | 42332185 | PubTator, text mining | PubMed |
| Incorporating Genetics Into Nephrology Practice-The New National Kidney Foundation Guidelines for Genetic Testing. | Adv Kidney Dis Health | 2026 | 42331439 | PubTator, text mining | PubMed |
| Apolipoprotein L1 Gene Genotype and Kidney Outcomes After Living Kidney Donation. | JAMA Intern Med | 2026 | 42329639 | PubTator, text mining | PubMed |
| Albuminuria Changes as a surrogate endpoint in Apolipoprotein L1 Mediated Kidney Disease in Vanderbilt BioVU and the Million Veteran Program. | medRxiv | 2026 | 42326799 | PubTator, text mining | PubMed |
| When Cure Meets Susceptibility: APOL1 -Associated Kidney Injury After Gene Therapy for Sickle Cell Disease. | Am J Hematol | 2026 | 42324706 | PubTator, text mining | PubMed |
| Genome-wide screen identifies peroxisomal role in APOL1 podocytopathy. | Kidney Int | 2026 | 42309203 | PubTator, text mining | PubMed |
| Kidney disease in patients with two APOL1 risk variants. | Kidney Res Clin Pract | 2026 | 42299451 | PubTator, text mining | PubMed |
| Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity. | J Am Soc Nephrol | 2026 | 42295851 | PubTator, text mining | PubMed |
| Proteomic prediction of APOL1-associated kidney disease. | Nat Genet | 2026 | 42286201 | PubTator, text mining | PubMed |
| APOL1 and chronic kidney disease in pediatrics: a study from the Biorepository and Integrative Genomics Initiative. | Pediatr Nephrol | 2026 | 42283832 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8542/papers?page=2